Patent reform being used as bargaining chip at expense of Canadians’ health.
Davies: “Studies project the patent extensions proposed by the EU could raise Canadians’ drug costs by $2.8 billion a year.”
“Changing the patent regime for pharmaceuticals is a complicated issue with deep consequences for Canadians, provincial healthcare programs, and Canadian employers,” said Davies (Vancouver-Kingsway). “Studies project the patent extensions proposed by the EU could raise Canadians’ drug costs by $2.8 billion a year.”
Drug costs are the second leading health care costs for provinces and are rising every year. A recent report reveals that many low income Canadians cannot afford the cost of their medicines and one in four are simply not filling their prescriptions.